At least 27 specialised clinics have been established nationwide, including in Karachi, to provide free treatment for ...

TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, ...

"In people with Type 1 diabetes, the immune system starts to recognize pancreatic cells as something it needs to attack, and ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

A new study from the Karolinska Institutet in Sweden has found that a common type of diabetes medicine might also help ...

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

Even after years of research, Type 1 diabetes has no cure — though glimpses of potential promise are out there. Treatment is directed toward managing the amount of sugar in the blood using ...

A record entirely from the South, in a sector that has always been a thorn in the side. At the University Hospital of Palermo ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...